ABBV
AbbVie IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$378.98B
P/E Ratio
105.15
EPS
$2.04
Beta
0.30
52W High
$239.13
52W Low
$176.00
50-Day MA
$208.51
200-Day MA
$219.14
Dividend Yield
3.17%
Profit Margin
5.79%
Forward P/E
15.04
PEG Ratio
0.59
About AbbVie Inc
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Fundamentals
| Revenue (TTM) | $62.82B |
| Gross Profit (TTM) | $45.25B |
| EBITDA | $29.92B |
| Operating Margin | 32.20% |
| Return on Equity | 62.30% |
| Return on Assets | 10.00% |
| Revenue/Share (TTM) | $35.50 |
| Book Value | $-3.77 |
| Price-to-Book | 50.46 |
| Price-to-Sales (TTM) | 6.03 |
| EV/Revenue | 7.04 |
| EV/EBITDA | 26.15 |
| Quarterly Earnings Growth (YoY) | -46.20% |
| Quarterly Revenue Growth (YoY) | 12.40% |
| Shares Outstanding | $1.77B |
| Float | $1.76B |
| % Insiders | 0.11% |
| % Institutions | 77.04% |
Historical Volatility
HV 10-Day
16.29%
HV 20-Day
23.63%
HV 30-Day
23.00%
HV 60-Day
25.44%
HV Rank
27.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($252.90 target)
8
Strong Buy16
Buy8
HoldMore HEALTHCARE Stocks
Data last updated: 5/23/2026